Enanta Pharmaceuticals, Inc. (15)

Browse by Contract Category

Contracts

Open Market Sale AgreementSM dated August 26, 2022, by and between Enanta Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on August 26, 2022)
First Amendment to Lease Agreement made as of May 12, 2022 by and between ARE-MA Region No. 75, LLC and the Company (Filed With SEC on May 17, 2022)
Form of Consulting Agreement (Amended and Restated), Nathalie Adda (Filed With SEC on May 9, 2022)
Second Amendment to Lease made as of May 12, 2022 by and between ARE-500 Arsenal Street, LLC and the Company (Filed With SEC on May 17, 2022)
Lease Agreement made as of May 12, 2022 by and between ARE-MA Region No. 75, LLC and the Company (Filed With SEC on May 17, 2022)
2019 Equity Incentive Plan (As amended through March 3, 2022) (Filed With SEC on March 8, 2022)
Consulting Agreement with Nathalie Adda (Filed With SEC on November 24, 2021)
2019 Equity Incentive Plan (As amended March 2021) (Filed With SEC on March 5, 2021)
Form of Notice of Restricted Stock Unit Award under 2019 Equity Incentive Plan (Filed With SEC on November 25, 2020)
Description of securities (Filed With SEC on November 27, 2019)
Form of Notice of Grant of Non-Statutory Stock Option under 2019 Equity Incentive Plan (Filed With SEC on May 10, 2019)
Form of Notice of Grant of Non-Statutory Stock Option for Directors under 2019 Equity Incentive Plan (Filed With SEC on May 10, 2019)
Form of Relative Total Stockholder Return Unit Certificate under 2019 Equity Incentive Plan (Filed With SEC on May 10, 2019)
Form of Performance Share Unit Certificate under 2019 Equity Incentive Plan (Filed With SEC on May 10, 2019)
2019 Equity Incentive Plan (Filed With SEC on March 7, 2019)